MRI is a powerful diagnostic tool, but the size and cost limits where it can be used. A compact, affordable new MRI system uses a much smaller magnetic field and doesn’t require shielding, and is still able to diagnose brain disorders in patients.

Source of Article

A study has found epileptic children treated with whole plant cannabis products displayed reductions in seizure frequency. The researchers call for clinical trials to test whether whole plant products are better at treating epilepsy than CBD alone.

Source of Article

Researchers in China have developed a new three-pronged method to fight liver cancer that shows promise in tests in mice. The technique combines drugs and CRISPR-Cas9 gene editing into lipid nanoparticles, then activates them with ultrasound.

Source of Article

Scientists at Harvard University have made a breakthrough that implicates a newly discovered hormone in the onset of diabetes, and shown how it can be targeted to reverse the effects of the disease.

Source of Article

There may be new hope for people with certain types of blindness, as an experimental sight-restoring device has been deemed safe for implantation. It still has to be tested on humans, though, and it will likely provide a rudimentary form of vision.

Source of Article

Researchers at Princeton focusing on a single gene central to the ability of most major cancers to metastasize have discovered what they describe as a "silver bullet," in the form of a compound that can disable this gene in mice and human tissue.

Source of Article

For people with coronary heart disease, regular monitoring of bloodstream cholesterol levels is essential – and it typically requires the drawing of blood samples. A new system, however, is claimed to provide the same data simply by imaging the skin of the hand.

Source of Article

A new study has shed light on a molecular process underpinning impaired metabolism and endurance in skeletal muscle associated with obesity, and reveals how a growth factor found in a South American plant can alleviate these deleterious effects.

Source of Article

Yale researchers have developed a new oral medication for type 1 diabetes. In tests in mice, the drug quickly adjusted insulin levels, restored metabolic functions and reversed inflammation, paving the way for a possible preventative for the disease.

Source of Article

A new study is reporting more than one in three patients trialing the recently approved Alzheimer’s drug aducanumab experienced brain swelling side effects. The data is the first from the drug’s Phase 3 trials to be peer-reviewed and published.

Source of Article